NEW YORK (Reuters) - A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S.

Jefferies analyst Akash Tewari maintained a Buy rating on Apellis Pharmaceuticals (APLS – Research Report) today and set a price target of ...

Biotech-stock investing has one tough test for success - and it's about to get easier ...

We recently compiled a list of the Jim Cramer Talked About These 11 Stocks Recently. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other stocks Jim ...

Amid a solid earnings picture for the third quarter, many US-listed companies are beating estimates. Combining the results of ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

“ [Trump’s plans] will come at the expense of potentially larger budget deficits, potentially larger debt and there is also ...

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...

Zoetis, a leading animal health company, has shown impressive growth with a 17.55% CAGR since its IPO. Read why I rate ZTS ...

Shares are mixed in Asia after U.S. stocks fell to their worst loss since Election Day. Japan's benchmark lost 1% while ...

The S&P 500 fell 2% in the past week, erasing more than half its gains from a post-election surge fueled in part by optimism ...